LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.89 | 771.67 | 2582 | 2397 | 1.0768 | 1.0926 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 24.89 | 771.67 | 2179 | 2397 | 0.9088 | 0.8864 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.11 | 771.67 | 2842 | 2675 | 1.0624 | 1.0686 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 27.11 | 771.67 | 2413 | 2675 | 0.9020 | 0.8883 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.33 | 771.67 | 3102 | 2939 | 1.0553 | 1.0566 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 29.33 | 771.67 | 2680 | 2939 | 0.9118 | 0.9065 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 31.55 | 771.67 | 3409 | 3196 | 1.0664 | 1.0637 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 31.55 | 771.67 | 2887 | 3196 | 0.9031 | 0.9030 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 33.78 | 771.67 | 3647 | 3499 | 1.0421 | 1.0382 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 33.78 | 771.67 | 3201 | 3499 | 0.9147 | 0.9199 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.00 | 771.67 | 3951 | 3884 | 1.0171 | 1.0146 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 36.00 | 771.67 | 3493 | 3884 | 0.8992 | 0.9109 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 38.22 | 771.67 | 4248 | 4299 | 0.9880 | 0.9903 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 38.22 | 771.67 | 3850 | 4299 | 0.8954 | 0.9128 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 40.44 | 771.67 | 4585 | 4738 | 0.9676 | 0.9750 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 40.44 | 771.67 | 4229 | 4738 | 0.8925 | 0.9150 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.67 | 771.67 | 4901 | 5155 | 0.9506 | 0.9634 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 42.67 | 771.67 | 4648 | 5155 | 0.9015 | 0.9257 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.89 | 771.67 | 5246 | 5541 | 0.9467 | 0.9618 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 44.89 | 771.67 | 4975 | 5541 | 0.8978 | 0.9256 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.11 | 771.67 | 5551 | 5941 | 0.9343 | 0.9544 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.11 | 771.67 | 5342 | 5941 | 0.8991 | 0.9291 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.33 | 771.67 | 5859 | 6392 | 0.9165 | 0.9437 | MN20160304_L01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.33 | 771.67 | 5730 | 6392 | 0.8964 | 0.9295 | MN20160304_L01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.55 | 771.67 | 6234 | 6829 | 0.9128 | 0.9428 | MN20160304_L01 | C22 |